Get the Stockscreener App
0.542
3.56%
-0.02
After Hours:
.54
-0.002
-0.37%
Virax Biolabs Group Ltd stock is traded at $0.542, with a volume of 841.98K.
It is down -3.56% in the last 24 hours and down -12.07% over the past month.
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
See More
Previous Close:
$0.562
Open:
$0.561
24h Volume:
841.98K
Relative Volume:
1.42
Market Cap:
$2.35M
Revenue:
$79,300
Net Income/Loss:
$-6.92M
P/E Ratio:
-0.0286
EPS:
-18.9818
Net Cash Flow:
$-5.34M
1W Performance:
-7.21%
1M Performance:
-12.07%
6M Performance:
-46.60%
1Y Performance:
-73.43%
1-Day Range:
$0.5312
$0.57
1-Week Range:
$0.5312
$0.64
52-Week Range:
$0.5202
$3.20
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Name
Virax Biolabs Group Ltd
Sector
Industry
Phone
-
Address
-
Compare VRAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.542 | 2.44M | 79,300 | -6.92M | -5.34M | -18.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Initiated | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd Stock (VRAX) Latest News
Real time breakdown of Virax Biolabs Group Limited stock performanceWeekly Volume Report & Technical Pattern Recognition Alerts - newser.com
Virax Biolabs (NASDAQ: VRAX) receives FDA pre-submission feedback; UK PAIS study at 160 - Stock Titan
Ranking Virax Biolabs Group Limited among high performing stocks via tools2025 Price Action Summary & Smart Investment Allocation Tips - newser.com
Will Virax Biolabs Group Limited stock gain from lower inflationTrade Volume Summary & Real-Time Buy Zone Alerts - newser.com
What margin trends mean for Virax Biolabs Group Limited stockEarnings Trend Report & Daily Technical Forecast Reports - newser.com
Why Virax Biolabs Group Limited stock attracts high net worth investorsPortfolio Gains Report & Real-Time Volume Spike Alerts - newser.com
Cosmos Health expands distribution of Avian Influenza kits - MSN
Is Virax Biolabs Group Limited stock attractive for passive investors2025 Short Interest & Daily Technical Stock Forecast Reports - newser.com
Will Virax Biolabs Group Limited stock split again soonJuly 2025 Catalysts & Capital Efficiency Focused Strategies - newser.com
How strong is Virax Biolabs Group Limited stock balance sheetJuly 2025 Fed Impact & AI Driven Price Forecasts - newser.com
What data driven models say about Virax Biolabs Group Limited’s future2025 AllTime Highs & Low Drawdown Investment Ideas - newser.com
Is Virax Biolabs Group Limited stock supported by strong fundamentalsJuly 2025 Highlights & Growth Oriented Trade Recommendations - newser.com
Does Virax Biolabs Group Limited stock trade at a discount to peersWeekly Profit Analysis & Expert Curated Trade Setup Alerts - newser.com
Using Bollinger Bands to evaluate Virax Biolabs Group LimitedQuarterly Performance Summary & Precise Entry and Exit Recommendations - newser.com
How sentiment analysis helps forecast Virax Biolabs Group Limited2025 AllTime Highs & Daily Chart Pattern Signals - newser.com
Will earnings trigger a reversal in Virax Biolabs Group Limited2025 Key Lessons & Low Risk High Win Rate Picks - newser.com
Using RSI to spot recovery in Virax Biolabs Group LimitedPortfolio Profit Report & Verified Swing Trading Watchlists - newser.com
How to build a dashboard for Virax Biolabs Group Limited stockIPO Watch & Technical Entry and Exit Tips - newser.com
Should you hold or exit Virax Biolabs Group Limited now2025 Year in Review & Free Community Consensus Stock Picks - newser.com
Long term hold vs stop loss in Virax Biolabs Group Limited2025 Biggest Moves & Daily Stock Trend Watchlist - newser.com
Is Virax Biolabs Group Limited stock ready for a breakout2025 Fundamental Recap & Precise Trade Entry Recommendations - newser.com
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Update - Defense World
What momentum indicators show for Virax Biolabs Group Limited stockJuly 2025 Recap & Technical Pattern Recognition Alerts - nchmf.gov.vn
Published on: 2025-10-18 09:57:05 - newser.com
Published on: 2025-10-15 10:01:25 - newser.com
Why Virax Biolabs Group Limited stock could rally in 2025Weekly Risk Summary & Precise Buy Zone Tips - newser.com
What the charts say about Virax Biolabs Group Limited todayWeekly Investment Recap & AI Based Buy and Sell Signals - newser.com
Custom watchlist performance reports with Virax Biolabs Group LimitedInsider Selling & Free Expert Verified Stock Movement Alerts - newser.com
What Fibonacci levels say about Virax Biolabs Group Limited rebound2025 Major Catalysts & Weekly High Return Opportunities - newser.com
Analyzing recovery setups for Virax Biolabs Group Limited investorsAnalyst Upgrade & Proven Capital Preservation Methods - newser.com
Can you recover from losses in Virax Biolabs Group Limited2025 Winners & Losers & Free Community Supported Trade Ideas - newser.com
Why Virax Biolabs Group Limited stock could outperform in 2025Portfolio Update Summary & Long-Term Safe Investment Plans - newser.com
How to escape a deep drawdown in Virax Biolabs Group LimitedJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com
Historical volatility pattern of Virax Biolabs Group Limited visualizedWeekly Investment Recap & Entry Point Confirmation Alerts - newser.com
Virax Biolabs Group Ltd Stock (VRAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):